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ABSTRACT 
 
 A case of leptospirosis complicated with meningomyeloencephalopolyneuritis and nephrotic 
syndrome is presented.  Anti-ganglioside antibodies were detected for the first time in a patient with 
neurological complications of leptospirosis. Possible pathogenic mechanisms and treatment options of 
these rare manifestations are discussed. 
 
BACKGROUND 
 
Leptospirosis is an important zoonosis with worldwide distribution. The severity of Leptospira 
infection ranges from a subclinical illness to two clinically recognizable syndromes: a self-limited, 
systemic illness and a severe illness (Weil's disease).  
The course of disease is biphasic. The first is an acute, septic phase which lasts 3 to 7 days. 
This is followed by an immune phase which lasts from 4 to 30 days. Systemic vasculitis accounts for 
protean clinical manifestations of the disease, while circulating antibodies are responsible for the 
development of aseptic meningitis, uveitis, iritis, iridocyclitis and chorioretinitis (1). 
Aseptic meningitis occurs in up to 80% of patients in the second, immune phase of the 
disease. It usually has a benign clinical course.  More severe neurological complications of 
leptospirosis are rare (2-4).  
Renal involvement is common in leptospirosis. Interstitial nephritis and tubular necrosis are 
common renal lesions which may progress to acute renal failure. Hemodynamic alterations, immune 
response, and direct nephrotoxicity may all lead to renal damage in the patients with leptospirosis. 
Damage to the glomerular capillary wall is usually not apparent and therefore not of clinical 
significance (5). We report a case of leptospirosis complicated with severe 
meningomyeloencephalopolyneuritis and nephrotic syndrome treated in our Intensive Care Unit. 
 
 
CASE REPORT 
 
 A 69-year-old white man was admitted to another, county hospital in October 2005 with a 
four-day history of fever, jaundice, lack of appetite and malaise. Three days after admission he was 
transferred to our hospital for suspected Weil's disease. He received ampicillin for three days at the 
county hospital. 
 The patient's medical history revealed arterial hypertension and peptic ulcer disease. He was a 
heavy smoker. The patient came from a rural area where leptospirosis is endemic.  
 On physical examination he was afebrile and icteric. Neurological examination revealed no 
abnormalities. Glasgow Coma Score was 15. Antibiotic treatment was continued. 
 Laboratory tests revealed a leukocyte count of 25,3 x 109/L (lymphocytes 2,5 x 109/L , 
neutrophils 22,3 x 109/L and monocytes 0,5 x 109/L), thrombocyte count of 60 x 109/L and a mild 
normocytic normochromic anemia (erythrocyte count was 3,78 x 1012/L, haemoglobin concentration 
10,5 g/dL, MCV 80 fL, MCH 27,8 pg and MCHC 34,4 g/dL). Erythrocyte sedimentation rate was 54 
mm per hour.  Urinalysis revealed moderate albuminuria, microhematuria and bilirubinuria. Urine pH 
was 5.0 and specific gravity was 1.018. Blood levels of glucose, lactate dehydrogenase (LDH), 
amylase, creatine kinase (CK), gamma-glutamyl transferase (γGT), calcium, magnesium, phosphorus 
and alkaline phosphatase were all normal. Prothrombin and partial-thromboplastin times were normal. 
Other laboratory findings at admission are shown in Table 1. Chest radiography and electrocardiogram 
showed no abnormalities. 
Over the next two days the patient’s condition deteriorated. He became febrile, lethargic and 
developed respiratory failure. Meningeal signs were positive.  Neurological examinations revealed 
simultaneous and rapidly progressive flaccid quadriplegia, areflexia, intercostal and diaphragmatic 
palsy. Plantar responses were absent. There were no signs of ophthalmoplegia, pupillary abnormality, 
facial or bulbar palsy. The patient was intubated and mechanical ventilation was started. 
Lumbar puncture revealed meningitis with 507 white cells per cubic millimeter with 58% 
neutrophils and 42% monocytes. Glucose and chloride levels were normal and the total protein level 
was 1,615 g/L. Blood-brain barrier dysfunction with intrathecal antibody synthesis was found. 
Cerebrospinal fluid (CSF), urine and blood cultures were negative. Calcium, magnesium and 
phosphorus concentrations were normal.  
Within the same period of time, the patient developed heavy proteinuria (2220 mg/24 h) with 
severe hypoalbuminaemia (18 g/L), peripheral edema and bilateral pleural effusion. A diagnosis of 
nephrotic syndrome was established. 
Brain and cervical spine MRI and CT scan were normal. Electroencephalogram showed 
marked diffuse slowing.  Unfortunately, electrophysiological examination was not performed for 
technical reasons.   
Although leptospirosis was suspected, because of the patient’s unusual complications 
extensive microbiological diagnostic tests were done to exclude infections from other pathogens. Stool 
samples for isolation of polio I, II and III viruses, echoviruses, and coxsackieviruses were negative. 
Tests for antibodies (blood and CSF samples) against herpes simplex virus 1 and 2, varicella-zoster 
virus, human herpes virus type 6, Epstein-Barr virus, cytomegalovirus, tick-borne encephalitis virus, 
Mycoplasma pneumoniae, Chlamydia pneumoniae, Borrelia burgdorferi, and Brucella were negative. 
Serology against hepatitis A, B and C was also negative. 
 Current leptospiral infection was serologically confirmed by microscopic agglutination test 
(MAT) on the tenth day of disease.  MAT titers of 1:4000 to L. australis, 1:2000 to L. pomona and 
1:2000 to L. hardjo serovars were found.  
During the following week, the patient's condition improved. He became afebrile, alert and 
with preserved sensorium. Motor neurological deficit with areflexia, though, remained unchanged. 
High-dose corticosteroid treatment (dexamethasone 4x12 mg IV) was started but without any effect on 
neurological symptoms or nephrotic syndrome. Because of diaphragmatic palsy prolonged mechanical 
ventilation was continued for up to 21 days.  
CSF examination during the third week of disease revealed cytoalbuminological dissociation 
(total protein level 1,207 g/L and leukocyte count was 3 cells per cubic millimeter). Glucose and 
chloride levels were normal.  
Anti-ganglioside antibodies were assessed by the semiquantitative GanglioCombi ELISA test 
(Buhlmann Laboratories AG, Basel, Switzerland) on the 21st day of disease. The serum GM1 and 
asialo-GM1 antibodies were weak positive, whereas GD1a antibodies were positive. Anti-GM2, anti-
GD1b and anti-GQ1b were negative. 
The mild renal non-oliguric failure and the liver lesion recovered completely within two 
weeks. The nephrotic syndrome resolved spontaneously one month after disease onset. 
 During the fourth week of the disease, a very slow neurological recovery began. The patient 
was transferred to a rehabilitation center two months after disease onset. Rehabilitation was successful 
and the patient was able to walk without assistance three months after discharge from the hospital. 
 
DISCUSSION 
 
 We report a rare case of leptospirosis complicated with severe neurological complications and 
nephrotic syndrome. We, for the first time, report an association of anti-ganglioside antibodies with 
severe neurological complications of leptospirosis. 
Neurological complications of leptospirosis affecting the central and peripheral nervous 
systems have been previously described. The most commonly reported syndromes include 
encephalitis, myelitis, cerebrovascular accidents, cerebral angiitis, mononeuritis multiplex, 
polyneuropathy, cranial nerve palsies, and movement disorders (2, 4, 6, 7, 8).  The majority of these 
complications occur in the later course of the disease, during the immune phase. However, 
neurological symptoms and signs can even precede the clinically apparent leptospirosis. This fact is of 
outstanding clinical importance (3).  
Presumed pathogenic mechanisms include both direct effect of leptospires and immune-
mediated injuries of the central nervous system. These proposed pathogenic mechanisms have not 
been completely elucidated (4).  Diffuse vasculitis occurring during and after the initial phase seems to 
be responsible for most of the neurological syndromes, while circulating immune complexes could be 
associated with the other syndromes observed in the second (immune) phase of the disease.   
The association of some anti-ganglioside antibodies with inflammatory 
polyradiculoneuropathies and related diseases (e.g. Bickerstaff encephalitis) has already been 
established (9, 10). Furthermore, some antibodies show a particular relationship with some clinical 
syndromes and triggering infectious agents [e.g. anti-GM1 with Campylobacter jejuni and acute motor 
axonal neuropathy (AMAN)] (9-11). 
The molecular mimicry between infectious agents and gangliosides may function in the 
production of anti-ganglioside antibodies. Antibodies can bind to nodes of Ranvier and fix 
complement which results in conduction block. Anti-GD1a ganglioside antibodies are almost 
exclusively associated with acute motor axonal form of the post-infectious polyneuropathies (12). 
Hence, such pathogenic mechanisms could explain some of the neurological syndromes seen in 
leptospirosis. The presence of anti-ganglioside antibodies has not been previously reported in patients 
with neurological complications of leptospirosis, even in those with polyradiculoneuropathy. Positive 
anti-ganglioside antibodies and a compatible clinical picture in our patient strongly suggest that 
neurological impairment was due to a diffuse, immune-mediated process. Another immunologically 
mediated complication which occurred  in our patient was nephrotic syndrome.   
Our findings confirm that leptospires can induce the production of anti-GD1a and anti-GM1 
antibodies and cause post-infectious polyneuropathy. However, this fact does not explain diffuse 
affection of the nervous system. Leptospires seem to be capable of inducing a diverse spectrum of 
pathogenic mechanisms at the same time. That is probably the reason for steroid treatment failure 
previously observed in neuroleptospirosis. 
Therefore, steroid use in patients suffering from severe forms of disease is controversial. Total 
plasma exchange (TPE) or intravenous immunoglobulins (IVIG) could be beneficial in these patients 
but to date, few data support these treatment choices. In mild cases no treatment is necessary. 
We conclude that our patient suffered from leptospiral immune-mediated 
meningomyeloencephalitis with overlapping acute motor axonal neuropathy and nephrotic syndrome. 
This is the first report of simultaneous diffuse nervous system dysfunction associated with the 
presence of anti-ganglioside antibodies and nephrotic syndrome during the course of leptospirosis.  
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TABLE 1   Laboratory findings at admission 
 
 
 value normal range units 
Serum 
C-reactive protein 
 
89 
 
<5 
 
mg/L 
fibrinogen 5,92 1,8-3,5 g/L 
glucose 5,5 4,2-6,4 mmol/L 
sodium 127 137-146 mmol/L 
potassium 3,3 3,9-5,1 mmol/L 
chloride 94 97-108 mmol/L 
urea nitrogen 14,9 2,8-8,3 mmol/L 
creatinin 140 79-125 μmol/L 
bilirubin - total 
                            direct 
                            indirect 
228,4 
129,3 
99,1 
3-20 
<5 
μmol/L 
aspartate aminotransferases 51 
 
11-38 U/L 
alanine aminotransferases 52 12-48 U/L 
total protein 
             albumin 
             globulin 
 
59 
24 
35 
66-81 
38-52 
24-34 
g/L 
 
Cerebrospinal fluid 
 
          cells/mm3 
                        neutrophils 
                         monocytes 
 
          protein 
          glucose 
          chloride 
 
 
 
507 
294 
213 
 
1,615 
3,0 
120 
 
 
 
3-5 
 
 
 
0,15-0,45 
2,25-4,0 
118-132 
 
 
 
 
 
 
 
g/L 
mmol/L 
mmol/L 
 
 
